AA

Ashraf Attia

Mr Attia has had senior management experience in multinational operations for over 30 years within the medical devices, biotechnology and diagnostics industries. He is currently Chief Executive Officer of Bionic Vision Technologies. Prior to Bionic Vision, Ash held the position of Vice President of Asia Pacific, Middle East and Israel at TransMedics Inc. He has held several senior executive roles with global medical devices organizations and has experience in the areas of commercialization, business development, clinical, regulatory, R&D, strategic marketing, sales and distribution management. He is Member of Risk Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
DVL
DVL
06/10/23624,973N/A11,191,109N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
DVL
DVL
06/10/23
Issued
1,000,001$0.011$11,000Issue of options
DVL
DVL
03/07/23
Issued
1,000,001$0.011$11,000Issue of options
DVL
DVL
03/04/23
Issued
733,334$0.001$1,100Issue of options
DVL
DVL
03/01/23
Issued
916,668$0.001$1,100Issue of options
DVL
DVL
03/10/22
Issued
785,715$0.001$1,100Director remuneration